ELMMB logo
Facebook logo Twitter logo

Valproate - Pregnancy Prevention Programme

Valproate - Pregnancy Prevention Programme


 The National Director for Patient Safety is writing to women and girls aged 12-55 who are currently prescribed sodium valproate 
 to advise them to contact their clinician for a review. We know that some women, who are currently prescribed sodium valproate,  
 may not be aware of the risks of taking it during pregnancy or of the need to use effective female contraception such as a coil
 or an implant. Good communication between the specialist prescriber and the health professional is essential to ensure the safe 
 prescribing of valproate in primary care and a shared care protocol is being developed to support this and will be available later 
 this year. 
 Please visit our website for more information.

Here are some links to resources to ensure women and girls of childbearing potential on valproate medicines meet the requirements of the Pregnancy Prevention Programme.  updated January 2020
Valproate specialist review referral form
(Contact details of who to refer to and an EMIS template referral form is available from medicines management.   Please contact your practice pharmacist for details on how to access these)

Valproate Guide for Healthcare Professionals  updated January 2020

Valproate Patient Guide Booklet  updated January 2020

Valproate Patient Information Card